GLP-1 receptor agonists in comparison with SGLT-2 inhibitors

被引：0
|
作者：
Pavlicek, Vojtech [1 ]
机构：
[1] Kantonsspital Munsterlingen, Med Klin, Endokrinol Diabetol & Klin Ernahrung, Spitalcampus 1, CH-8596 Munsterlingen, Switzerland
来源：
DIABETOLOGE | 2020年 / 16卷 / 05期
关键词：
D O I：
10.1007/s11428-020-00644-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：530 / 531
页数：2
相关论文
共 50 条
  • [1] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411
  • [2] Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
    Bailey, Clifford J.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02): : 97 - 99
  • [3] Impact of GLP-1 receptor agonists versus SGLT-2 inhibitors on diabetic retinopathy
    Joo, Julia
    Sharma, Neha
    Daugirdas, Sarunas
    Wu, Anna K.
    Russell, Matthew W.
    Skugor, Mario
    Singh, Rishi
    Rachitskaya, Aleksandra V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists
    Chen, Jia-Jin
    Lee, Tao-Han
    Yang, Huang-Yu
    KIDNEY INTERNATIONAL, 2024, 105 (03) : 442 - 444
  • [5] Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
    Prattichizzo, Francesco
    Candia, Paola de
    Ceriello, Antonio
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 120
  • [6] Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists
    Khedagi, Apurva
    Hoke, Cara
    Kelsey, Michelle
    Coviello, Andrea
    Jones, W. Schuyler
    Jackson II, Larry R.
    Patel, Manesh R.
    McGarrah, Rob W.
    Pagidipati, Neha J.
    Shah, Nishant P.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 13
  • [7] Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 173 - 173
  • [8] Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults
    Dadwani, Rahul S.
    Wan, Wen
    Skandari, M. Reza
    Huang, Elbert S.
    MDM POLICY & PRACTICE, 2023, 8 (02)
  • [9] SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation
    Arnold, Michael J.
    Buelt, Andrew
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (06) : 675 - 677
  • [10] GLP-1 agonists and SGLT-2 inhibitors in adults with sickle cell disease
    Sun, Ryan
    Srivastava, Anand
    Derebail, Vimal K.
    Han, Jin
    Molokie, Robert E.
    Gordeuk, Victor
    Saraf, Santosh L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1610 - 1612
12345